Ikervis® (ciclosporin)
Severe Keratitis in Dry Eye Disease
ApprovedCommercial
Key Facts
Indication
Severe Keratitis in Dry Eye Disease
Phase
Approved
Status
Commercial
Company
About Santen Pharmaceutical
Santen Pharmaceutical is a leading global player in the ophthalmology market, dedicated to addressing unmet medical needs in eye diseases. The company leverages its deep expertise in ocular drug delivery and formulation to build a diversified portfolio spanning glaucoma, retinal diseases, dry eye, and inflammation. With a long history of innovation and a commitment to research, Santen aims to contribute to the well-being of patients worldwide through its specialized ophthalmic solutions.
View full company profile